0.00Open0.00Pre Close0 Volume0 Open Interest4.00Strike Price0.00Turnover764.96%IV-897.51%PremiumAug 16, 2024Expiry Date3.60Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.5737Delta0.5120Gamma0.11Leverage Ratio-0.0061Theta-0.0015Rho-0.06Eff Leverage0.0004Vega
Sangamo Therapeutics Stock Discussion
Sangamo Therapeutics recently presented critical pre-clinical data on its innovative next-generation integrase technology, the Modular Integrase (MINT) platform, highlighting a significant advancement in the field of genome editing. The announcement came as part of their participation at the 27th Amer...
No comment yet